Does SITAGLIPTIN Cause Hypercholesterolaemia? 95 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 95 reports of Hypercholesterolaemia have been filed in association with SITAGLIPTIN (JANUVIA). This represents 0.5% of all adverse event reports for SITAGLIPTIN.
95
Reports of Hypercholesterolaemia with SITAGLIPTIN
0.5%
of all SITAGLIPTIN reports
70
Deaths
85
Hospitalizations
How Dangerous Is Hypercholesterolaemia From SITAGLIPTIN?
Of the 95 reports, 70 (73.7%) resulted in death, 85 (89.5%) required hospitalization, and 28 (29.5%) were considered life-threatening.
Is Hypercholesterolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 95 reports have been filed with the FAERS database.
What Other Side Effects Does SITAGLIPTIN Cause?
Blood glucose increased (1,427)
Pancreatic carcinoma (1,142)
Product dose omission issue (1,125)
Drug ineffective (1,057)
No adverse event (994)
Nausea (936)
Pancreatitis (922)
Diabetes mellitus inadequate control (744)
Diarrhoea (712)
Hypoglycaemia (674)
What Other Drugs Cause Hypercholesterolaemia?
ALENDRONATE (1,607)
METHOTREXATE (1,547)
TOCILIZUMAB (1,483)
ADALIMUMAB (1,479)
ABATACEPT (1,410)
RITUXIMAB (1,389)
PREDNISONE (1,377)
INFLIXIMAB (1,338)
DICLOFENAC (1,331)
LEFLUNOMIDE (1,322)
Which SITAGLIPTIN Alternatives Have Lower Hypercholesterolaemia Risk?
SITAGLIPTIN vs SOAP
SITAGLIPTIN vs SODIUM
SITAGLIPTIN vs SODIUM BICARBONATE
SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM
SITAGLIPTIN vs SODIUM BORATE